Physician profile
Andre H Saad
NPI 1376534974
$1,965.73
in general payments reported to CMS, 2019-2025
14 companies · $54.31 in 2025
The $54.31 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $679 · 2020: $83.12 · 2021: $20.34 · 2022: $925 · 2023: $171 · 2024: $31.99 · 2025: $54.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $890.92 | 2022 | |
| Stryker Corporation | $461.63 | 2019 | |
| Medtronic Vascular, INC. | $247.70 | 2019-2020 | |
| Novo Nordisk INC | $118.71 | 2023 | Wegovy |
| Shield Therapeutics INC | $53.50 | 2023-2024 | Accrufer |
| Myovant Sciences INC. | $34.33 | 2022 | |
| Ge Healthcare | $30.74 | 2025 | |
| Olympus America INC. | $25.38 | 2019 | |
| Daiichi Sankyo INC. | $23.57 | 2025 | Injectafer |
| Abbvie INC. | $20.34 | 2021 | |
| Sumitomo Pharma America, INC. | $16.64 | 2023 | Myfembree |
| Roche Diagnostics Corporation | $15.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.53 | 2024 | |
| Allergan, INC. | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Saad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.